There is no shame in holding at a dose that works
Quick reference: retatrutide dosage chart This chart reflects the escalation schedule used in Phase 2 and Phase 3 clinical trials: Standard titration protocol (2mg start 12mg target) Alternative protocols by target dose Target: 8 mg maintenance Target: 4 mg maintenance Key principle: Start low, go slow
This group includes other notable drugs such as liraglutide (marketed as Victoza and Saxenda) and the newer tirzepatide (marketed as Zepbound and Mounjaro)
Genetic Predispositions in Peptide Pathways and Individual Response Timing Genetic variants in GLP-1 receptor (GLP1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) pathways may influence how quickly patients feel semaglutide's metabolic effects
These results provide us confidence to initiate MARITIME, a Phase III program across obesity and a number of related conditions, providing a unique potential new treatment option for patients. MariTide was well-tolerated across all dosage groups, with the most common side effects being mild gastrointestinal symptoms, such as nausea and diarrhea, which were largely mild, transient and primarily associated with the first dose, according to Amgen